2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26.
No abstract available

Keywords: ASCVD; Expert Consensus Decision Pathway; GLP-1RA; SGLT2 inhibitor; T2D; cardiovascular risk reduction; diabetes.

Publication types

  • Practice Guideline

MeSH terms

  • Atherosclerosis / complications*
  • Atherosclerosis / prevention & control
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Critical Pathways
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Humans